Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals

Tytuł:
Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals
Autorzy:
Giuseppe Della Pepa
Claudia Vetrani
Gianluca Lombardi
Lutgarda Bozzetto
Giovanni Annuzzi
Angela Albarosa Rivellese
Temat:
NAFLD
NASH
isocaloric dietary changes
carbohydrates
monounsaturated fatty acids
polyunsaturated fatty acids
polyphenols
vitamins
Nutrition. Foods and food supply
TX341-641
Źródło:
Nutrients, Vol 9, Iss 10, p 1065 (2017)
Wydawca:
MDPI AG, 2017.
Rok publikacji:
2017
Kolekcja:
LCC:Nutrition. Foods and food supply
Typ dokumentu:
article
Opis pliku:
electronic resource
Język:
English
ISSN:
2072-6643
Relacje:
https://www.mdpi.com/2072-6643/9/10/1065; https://doaj.org/toc/2072-6643
DOI:
10.3390/nu9101065
Dostęp URL:
https://doaj.org/article/adebd611e56f4066be9f718e0cce2496  Link otwiera się w nowym oknie
Numer akcesji:
edsdoj.bd611e56f4066be9f718e0cce2496
Czasopismo naukowe
Non-alcoholic fatty liver disease (NAFLD) incorporates an extensive spectrum of histologic liver abnormalities, varying from simple triglyceride accumulation in hepatocytes non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH), and it is the most frequent chronic liver disease in the industrialized world. Beyond liver related complications such as cirrhosis and hepatocellular carcinoma, NAFLD is also an emerging risk factor for type 2 diabetes and cardiovascular disease. Currently, lifestyle intervention including strategies to reduce body weight and to increase regular physical activity represents the mainstay of NAFLD management. Total caloric intake plays a very important role in both the development and the treatment of NAFLD; however, apart from the caloric restriction alone, modifying the quality of the diet and modulating either the macro- or micronutrient composition can also markedly affect the clinical evolution of NAFLD, offering a more realistic and feasible treatment alternative. The aim of the present review is to summarize currently available evidence from randomized controlled trials on the effects of different nutrients including carbohydrates, lipids, protein and other dietary components, in isocaloric conditions, on NAFLD in people at high cardiometabolic risk. We also describe the plausible mechanisms by which different dietary components could modulate liver fat content.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies